Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Workman

Showing results (21-30 of 268) with videos related to

Pageof 27
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|March 15, 2002
Overview: changing times: developing cancer drugs in genomelandP Workman
Cold Spring Harbor Symposia on Quantitative Biology|July 28, 2006
Drugging the cancer kinome: progress and challenges in developing personalized molecular cancer therapeuticsP Workman
International Journal of Radiation Oncology, Biology, Physics|April 1, 1989
Micropharmacokinetics of chemical modifiersP Workman
Cancer Cells (Cold Spring Harbor, N.Y. : 1989)|August 1, 1991
Antitumor ether lipids: endocytosis as a determinant of cellular sensitivityP Workman
Chemico-Biological Interactions|January 1, 1978
Inhibition of human prostatic tumour acid phosphatase by N,N-p-di-2-chloroethylaminophenol, N,N-p-di-2-chloroethylaminophenyl phosphate and other difunctional nitrogen mustardsP Workman
Current Opinion in Pharmacology|November 17, 2001
Scoring a bull's-eye against cancer genome targetsP Workman
European Journal of Cancer (Oxford, England : 1990)|October 22, 2002
Challenges of PK/PD measurements in modern drug developmentP Workman
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1993
The relevance of pharmacology in clinical oncology practice. The moderator thinks thatP Workman
Journal of Chromatography|August 21, 1979
Analysis of the basic 5-nitroimidazole nimorazole in blood by reversed-phase high-performance liquid chromatography, and its application to pharmacokinetic studies in individual miceP Workman
Cancer Chemotherapy and Pharmacology|January 1, 1980
Dose-dependence and related studies on the pharmacokinetics of misonidazole and desmethylmisonidazole in miceP Workman
Pageof 27

Showing results (21-30 of 268) with videos related to

Sort By:
Pageof 27
Current Opinion in Investigational Drugs (London, England : 2000)|March 15, 2002
Overview: changing times: developing cancer drugs in genomelandP Workman
Cold Spring Harbor Symposia on Quantitative Biology|July 28, 2006
Drugging the cancer kinome: progress and challenges in developing personalized molecular cancer therapeuticsP Workman
International Journal of Radiation Oncology, Biology, Physics|April 1, 1989
Micropharmacokinetics of chemical modifiersP Workman
Cancer Cells (Cold Spring Harbor, N.Y. : 1989)|August 1, 1991
Antitumor ether lipids: endocytosis as a determinant of cellular sensitivityP Workman
Chemico-Biological Interactions|January 1, 1978
Inhibition of human prostatic tumour acid phosphatase by N,N-p-di-2-chloroethylaminophenol, N,N-p-di-2-chloroethylaminophenyl phosphate and other difunctional nitrogen mustardsP Workman
Current Opinion in Pharmacology|November 17, 2001
Scoring a bull's-eye against cancer genome targetsP Workman
European Journal of Cancer (Oxford, England : 1990)|October 22, 2002
Challenges of PK/PD measurements in modern drug developmentP Workman
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1993
The relevance of pharmacology in clinical oncology practice. The moderator thinks thatP Workman
Journal of Chromatography|August 21, 1979
Analysis of the basic 5-nitroimidazole nimorazole in blood by reversed-phase high-performance liquid chromatography, and its application to pharmacokinetic studies in individual miceP Workman
Cancer Chemotherapy and Pharmacology|January 1, 1980
Dose-dependence and related studies on the pharmacokinetics of misonidazole and desmethylmisonidazole in miceP Workman
Pageof 27